Joseph H. Murray

Array ( [id] => 8920952 [patent_doc_number] => 08486886 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-16 [patent_title] => 'Botulinum toxin treatments' [patent_app_type] => utility [patent_app_number] => 13/478016 [patent_app_country] => US [patent_app_date] => 2012-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4327 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13478016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8725530 [patent_doc_number] => 08404646 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-26 [patent_title] => 'Methods for preventing or treating mitochondrial permeability transition' [patent_app_type] => utility [patent_app_number] => 13/247648 [patent_app_country] => US [patent_app_date] => 2011-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 13033 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13247648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561986 [patent_doc_number] => 20110275819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'ORGANIC COMPOUNDS AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 13/185683 [patent_app_country] => US [patent_app_date] => 2011-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 29289 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275819.pdf [firstpage_image] =>[orig_patent_app_number] => 13185683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8386168 [patent_doc_number] => 08263562 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Peptides for preventing or treating liver damage' [patent_app_type] => utility [patent_app_number] => 13/162981 [patent_app_country] => US [patent_app_date] => 2011-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 10720 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13162981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102587 [patent_doc_number] => 20110166080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'DEUTERATED CYCLOSPORINE ANALOGS AND METHODS OF MAKING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/048258 [patent_app_country] => US [patent_app_date] => 2011-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10773 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166080.pdf [firstpage_image] =>[orig_patent_app_number] => 13048258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5937338 [patent_doc_number] => 20110212885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'OPHTHALMIC AND CONTACT LENS SOLUTIONS CONTAINING PEPTIDES AS PRESERVATIVE' [patent_app_type] => utility [patent_app_number] => 13/037802 [patent_app_country] => US [patent_app_date] => 2011-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3465 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212885.pdf [firstpage_image] =>[orig_patent_app_number] => 13037802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6112680 [patent_doc_number] => 20110190138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING CONDITIONS' [patent_app_type] => utility [patent_app_number] => 13/012608 [patent_app_country] => US [patent_app_date] => 2011-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 25896 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190138.pdf [firstpage_image] =>[orig_patent_app_number] => 13012608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6148863 [patent_doc_number] => 20110020458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'SUSTAINED-RELEASE COMPOSITION OF DRUGS ENCAPSULATED IN MICROPARTICLES OF HYALURONIC ACID' [patent_app_type] => utility [patent_app_number] => 12/893203 [patent_app_country] => US [patent_app_date] => 2010-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7110 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020458.pdf [firstpage_image] =>[orig_patent_app_number] => 12893203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6276849 [patent_doc_number] => 20100256330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'Peptide-based compounds' [patent_app_type] => utility [patent_app_number] => 12/814621 [patent_app_country] => US [patent_app_date] => 2010-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7777 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256330.pdf [firstpage_image] =>[orig_patent_app_number] => 12814621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6633621 [patent_doc_number] => 20100311944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'CYCLOSPORINE ANALOGUE MIXTURES AND THEIR USE AS IMMUNOMODULATING AGENTS' [patent_app_type] => utility [patent_app_number] => 12/796616 [patent_app_country] => US [patent_app_date] => 2010-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 25075 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311944.pdf [firstpage_image] =>[orig_patent_app_number] => 12796616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8549545 [patent_doc_number] => 08324428 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Stabilized compounds having secondary structure motifs' [patent_app_type] => utility [patent_app_number] => 12/796212 [patent_app_country] => US [patent_app_date] => 2010-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 10545 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12796212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8968615 [patent_doc_number] => 08507426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-13 [patent_title] => 'Peptides and related molecules that bind to TALL-1' [patent_app_type] => utility [patent_app_number] => 12/788137 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 40 [patent_no_of_words] => 22751 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12788137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6266400 [patent_doc_number] => 20100298218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'Single Branch Heparin-Binding Growth Factor Analogs' [patent_app_type] => utility [patent_app_number] => 12/786256 [patent_app_country] => US [patent_app_date] => 2010-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16854 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298218.pdf [firstpage_image] =>[orig_patent_app_number] => 12786256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6465290 [patent_doc_number] => 20100190718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'METHODS FOR PREVENTING OR TREATING MITOCHONDRIAL PERMEABILITY TRANSITION' [patent_app_type] => utility [patent_app_number] => 12/753403 [patent_app_country] => US [patent_app_date] => 2010-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 13016 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190718.pdf [firstpage_image] =>[orig_patent_app_number] => 12753403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228970 [patent_doc_number] => 20100183708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Antigen Delivery Vectors and Constructs' [patent_app_type] => utility [patent_app_number] => 12/700566 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8258 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183708.pdf [firstpage_image] =>[orig_patent_app_number] => 12700566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228912 [patent_doc_number] => 20100183650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Antigen Delivery Vectors and Constructs' [patent_app_type] => utility [patent_app_number] => 12/700526 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8258 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183650.pdf [firstpage_image] =>[orig_patent_app_number] => 12700526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8082009 [patent_doc_number] => 08148322 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-03 [patent_title] => 'Method and carrier complexes for delivering molecules to cells' [patent_app_type] => utility [patent_app_number] => 12/631048 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17363 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 1518 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/148/08148322.pdf [firstpage_image] =>[orig_patent_app_number] => 12631048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8629898 [patent_doc_number] => 08361970 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-29 [patent_title] => 'Growth factor binding molecules' [patent_app_type] => utility [patent_app_number] => 12/622295 [patent_app_country] => US [patent_app_date] => 2009-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13152 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12622295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6236348 [patent_doc_number] => 20100267651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'T CELL ANTIGEN RECEPTOR PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/621793 [patent_app_country] => US [patent_app_date] => 2009-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 16506 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267651.pdf [firstpage_image] =>[orig_patent_app_number] => 12621793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6248777 [patent_doc_number] => 20100137227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/582008 [patent_app_country] => US [patent_app_date] => 2009-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 25766 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137227.pdf [firstpage_image] =>[orig_patent_app_number] => 12582008 [rel_patent_id] =>[rel_patent_doc_number] =>)